Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGAN INC Director's Dealing 2017

Feb 28, 2017

31210_dirs_2017-02-28_8b4a1e38-3267-499b-ac51-640222f0244f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARGAN INC (AGX)
CIK: 0000100591
Period of Report: 2017-01-05

Reporting Person: MITCHELL W G CHAMPION (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-01-05 Stock Option to purchase Common Stock $71.75 A 10000 Acquired 2027-01-05 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7500 Indirect

Footnotes

F1: The Reporting Person's previously filed Form 4 inadvertently identified these 7,500 shares as directly owned by the Reporting Person, which was a typo. The shares are held by MMAB, LLC, of which the Report Person owns 1% interest and 100% voting power.

F2: Pursuant to a stock option agreement dated January 5, 2017, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $71.75 per share.

F3: The total number of stock options owned by the Reporting Person includes options to acquire (i) 5,000 shares of Common Stock at an Exercise Price of $12.43 per share with Date Exercisable of 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of Common Stock at an Exercise Price of $17.33 per share with Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (v) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024;

F4: (vi) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027.